Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shuwen Biotech of Hangzhou Launches PD-L1 Test Kit

publication date: Sep 17, 2018

Shuwen Biotech of Hangzhou has launched a proprietary PD-L1 test kit, the first China company to offer a PD-L1 diagnostic, the company said. The kit is used to determine the expression levels of PD-L1 in tumor tissues. Shuwen said Hengrui Medicine used its kit in clinical trials of its PD-1 drug in patients with esophageal squamous cell carcinoma. The trial showed the PD-1 candidate produced a higher response rate in patients who were positive for PD-L1. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital